Su Fu

Su Fu is the Vice President of Corporate Development at Architect Therapeutics, an emerging biotechnology portfolio company originally backed by ARCH Venture Partners. Prior to assuming her current executive position, she served as a Senior Associate at ARCH Venture Partners, where she focused on evaluating early-stage venture capital investments and supporting portfolio companies within the broader life sciences sector. She earned a Master of Business Administration with specific academic concentrations in Entrepreneurship and Strategic Management from The University of Chicago Booth School of Business. Before pursuing her graduate business studies, she completed a Bachelor of Arts degree with a dual major in Chemistry and Economics from Smith College. Fu's career currently centers on bridging rigorous scientific research with institutional venture capital to drive corporate development initiatives for early-stage therapeutics companies and biotechnology startups.